Cevec Capr Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Accesswire. The AP news staff was not involved in its creation. CEVEC and CARISMA Therapeutics Sign License Agreement for the Use of CAP(R) Technology in Anti-Tumor Cell Therapies February 2, 2021 GMT CARISMA receives full rights to use the CAP(R) Technology for the production of adenoviral vectors across their whole portfolio of cell therapies for oncology applications CEVEC’s unique CAP(R) cells are specifically designed for highly scalable, RCA-free adenoviral vector manufacturing in suspension bioreactors The agreement supports CARISMA’s development of novel...

(0) DGAP-News: CEVEC Pharmaceuticals GmbH / Key word(s): Alliance CEVEC and CARISMA Therapeutics sign license agreement for the use of CAP(R) Technology in anti-tumor cell therapies 02.02.2021 / 14:00 The issuer is solely responsible for the content of this announcement. CEVEC and CARISMA Therapeutics sign license agreement for the use of CAP(R) Technology in anti-tumor cell therapies CARISMA receives full rights to use the CAP(R) Technology for the production of adenoviral vectors across their whole portfolio of cell therapies for oncology applications CEVEC's unique CAP(R) cells are spe...

CEVEC Pharmaceuticals GmbH CEVEC and CARISMA Therapeutics sign license agreement for the use of CAP(R) Technology in anti-tumor cell therapies DGAP-News: CEVEC Pharmaceuticals GmbH / Key word(s): Alliance CEVEC and CARISMA Therapeutics sign license agreement for the use of CAP(R) Technology in anti-tumor cell therapies 02.02.2021 / 14:00 The issuer is solely responsible for the content of this announcement. CEVEC and CARISMA Therapeutics sign license agreement for the use of CAP(R) Technology in anti-tumor cell therapies CARISMA receives full rights to use the CAP(R) Technology for the prod...